Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · IEX Real-Time Price · USD
3.060
-0.170 (-5.26%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Poseida Therapeutics Market Cap
Poseida Therapeutics has a market cap or net worth of $296.69 million as of July 22, 2024. Its market cap has increased by 103.49% in one year.
Market Cap
296.69M
Enterprise Value
182.61M
1-Year Change
103.49%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since July 10, 2020, Poseida Therapeutics's market cap has decreased from $948.90M to $296.69M, a decrease of -68.73%. That is a compound annual growth rate of -25.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 296.70M | -7.66% |
Dec 29, 2023 | 321.30M | -29.46% |
Dec 30, 2022 | 455.50M | 7.00% |
Dec 31, 2021 | 425.70M | -37.23% |
Dec 31, 2020 | 678.20M | -28.53% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Enanta Pharmaceuticals | 303.29M |
Atea Pharmaceuticals | 300.68M |
SOPHiA GENETICS | 299.42M |
Adaptimmune Therapeutics | 298.93M |
Verrica Pharmaceuticals | 298.64M |
Tactile Systems Technology | 294.18M |
Alimera Sciences | 291.80M |
Aquestive Therapeutics | 291.32M |